TSPO EXPRESSION IN PATIENTS WITH DIFFERENT CLINICAL AND MORPHOLOGICAL TYPES OF RENAL CELL CARCINOMA

R. A. Zukov , O. K. Polyakova , T. G. Ruksha , Yu. A. Dykhno , T. V. Maksimova

Russian Journal of Oncology ›› 2012, Vol. 17 ›› Issue (1) : 20 -23.

PDF
Russian Journal of Oncology ›› 2012, Vol. 17 ›› Issue (1) : 20 -23. DOI: 10.17816/onco39929
Articles
research-article

TSPO EXPRESSION IN PATIENTS WITH DIFFERENT CLINICAL AND MORPHOLOGICAL TYPES OF RENAL CELL CARCINOMA

Author information +
History +
PDF

Abstract

The paper presents the results of an investigation of the expression of peripheral benzodiazepine receptor (TsPO) in patients with renal cell carcinoma in relation to gender, age, disease stage, histological type, and comorbid diseases. In the patients with renal cell carcinoma, the level of TsPO was found to be related to the disease stage, histological type, and the presence of synchronous cancer at other sites. The findings may suggest that TsPO can be used as a marker in predicting the efficiency of treatment and the course of disease.

Keywords

TsPO / renal cell carcinoma / peripheral benzodiazepine receptor / TsPO / histological types of kidney cancer

Cite this article

Download citation ▾
R. A. Zukov, O. K. Polyakova, T. G. Ruksha, Yu. A. Dykhno, T. V. Maksimova. TSPO EXPRESSION IN PATIENTS WITH DIFFERENT CLINICAL AND MORPHOLOGICAL TYPES OF RENAL CELL CARCINOMA. Russian Journal of Oncology, 2012, 17(1): 20-23 DOI:10.17816/onco39929

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Cheville J. S., Lohse C. M., Zincke H. et al. // Am. J. Surg. Pathol. 2003. Vol. 27, N 5. P. 612-624.

[2]

Delahunt B., Eble J. N., McCredie M. R. et al. // Hum. Pathol. 2001. Vol. 32, N 6. P 590-595.

[3]

Everett H., Barry M., Sun X. et al. // J. Exp. Med. 2002. Vol. 196, N 9. P. 1127-1140.

[4]

Galiegue S., Casellas P., Kramar A. et al. // Clin. Cancer Res. 2004. Vol. 10. P. 2058-2064.

[5]

Gavish M., Laor N., Bidder M. et al. // Neuropsychopharmacology. 1996. Vol. 14, N 3. P. 181-186.

[6]

Han Z., Slack R. S., Li W. et al. // J. Recept. Signal Transduct. Res. 2003. Vol. 23, N 2-3. P. 225-238.

[7]

Johnson M. R., Marazziti D., Brawman-Mintzer O. et al. // Biol. Psychiatry. 1998. Vol. 43, N 4. P. 306-309.

[8]

Kurumaji A., Nomoto H., Yamada K. et al. // Am. J. Med. Genet. 2001. Vol. 105, N 2. P. 172-175.

[9]

Lin D., Chang Y. J., Strauss J. F. et al. // Genomics. 1993. - Vol. 18, N 3. P. 643-650.

[10]

Linehan W. M., Zbar B. // Cancer Cell. 2004. Vol. 6. - P. 223-228.

[11]

Maaser K., Grabowski P., Sutter A. P. et al. // Clin. Cancer Res. 2002. Vol. 8. P. 3205-3209.

[12]

Molina A. M., Tickoo S. K., Ishill N. et al. // J. Clin. Oncol. 2009. Vol. 27, N 15S. P. 16017.

[13]

Papadopoulos V., Baraldi M., Guilarte T. R. et al. // Trends Pharmacol. Sci. 2006. Vol. 27, N 8. P. 402-409.

[14]

Patard J.-J., Kim H. L., Lam J. S. et al. // J. Clin. Oncol. 2004. Vol. 22, N 16. P. 3316-3322.

[15]

Patard J.-J., Leray E., Rioux-Leclercq N. et al. // J. Clin. Oncol. 2005. Vol. 23, N 12. P. 2763-2771.

[16]

Pignot G., Elie C., Conquy S. et al. // J. Urology. 2007. Vol. 69, N 2. P. 230-235.

[17]

Ruff M. R., Pert C. B., Weber R. J. et al. // Science. 1985. - Vol. 229. P. 1281-1283.

[18]

Taliani S., Simorini F., Sergianni V. et al. // J. Med. Chem. 2007. Vol. 50, N 2. P. 404-407.

[19]

Veenman L., Gavish M. // Pharmacol. Ther. 2006. Vol. 110, N 3. P. 503-524.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

139

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/